KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Net Income towards Common Stockholders (2016 - 2025)

Teva Pharmaceutical Industries' Net Income towards Common Stockholders history spans 10 years, with the latest figure at $466.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Net Income towards Common Stockholders rose 265.25% year-over-year to $466.0 million, compared with a TTM value of $1.4 billion through Dec 2025, up 150.15%, and an annual FY2025 reading of $1.4 billion, up 171.12% over the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was $466.0 million at Teva Pharmaceutical Industries, up from $428.0 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $466.0 million in Q4 2025, with the low at -$2.1 billion in Q4 2022.
  • Average Net Income towards Common Stockholders over 5 years is -$691.9 million, with a median of -$699.5 million recorded in 2022.
  • Year-over-year, Net Income towards Common Stockholders plummeted 1394.2% in 2021 and then skyrocketed 265.25% in 2025.
  • Tracing TEVA's Net Income towards Common Stockholders over 5 years: stood at -$1.1 billion in 2021, then crashed by 90.51% to -$2.1 billion in 2022, then surged by 92.76% to -$154.0 million in 2023, then plummeted by 83.12% to -$282.0 million in 2024, then skyrocketed by 265.25% to $466.0 million in 2025.
  • Per Business Quant, the three most recent readings for TEVA's Net Income towards Common Stockholders are $466.0 million (Q4 2025), $428.0 million (Q3 2025), and $274.0 million (Q2 2025).